NGEN
NervGen Pharma·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-03-22
Latest data update time: Updated on 2026-03-22
6.38 / 10Overall Score
OutperformInvestment Rating
6.38 / 10Overall Score
OutperformInvestment Rating
Trend Analysis of NGEN
- Based on a composite score of 6.38/10, we rate NGEN as a Outperform. Our analysis breaks down into 5.84/10 for Fundamentals, 5.81/10 for Technicals, and 7.50/10 for Sentiment, indicating the stock is likely to See further upside.
Technical Analysis of NGEN?
Is NGEN undervalued or overvalued?
Is money flowing into or out of NGEN?
Trend Analysis of NGEN
- Based on a composite score of 6.38/10, we rate NGEN as a Outperform. Our analysis breaks down into 5.84/10 for Fundamentals, 5.81/10 for Technicals, and 7.50/10 for Sentiment, indicating the stock is likely to See further upside.
Is NGEN undervalued or overvalued?
Technical Analysis of NGEN?
Is money flowing into or out of NGEN?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
